1 minute reading time (100 words)

Risk of Fractures With Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants

The odds of breaking a bone are stacked against individuals using antidepressant drugs within the classes of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs).

This study assessed whether people taking medications belonging to the classes of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) have higher chances of suffering from fractures. Researchers collated data from 13 clinical studies.

Researchers observed that the likelihood of fracturing a bone was high among users of tricyclic antidepressants and selective serotonin reuptake inhibitors.This study adds to the growing body of evidence supporting the fracture-promoting effect of tricyclic antidepressants and selective serotonin reuptake inhibitors.

.

Research Summary Information

  • 2009
  • Regina Ginzburg , Enma Rosero
  • College of Pharmacy and Allied Health Professions, St. John's University, Jamaica, NY 11439, USA. ginzburr@stjohns.edu
  • No, Free full text of study was not found.
Selective Serotonin Reuptake Inhibiting Antidepres...
Seizure Risk Associated With Antidepressant Treatm...

Related Posts

 

Comments (0)

Rated 0 out of 5 based on 0 voters
There are no comments posted here yet

Leave your comments

  1. Posting comment as a guest. Sign up or login to your account.
Rate this post:
Attachments (0 / 3)
Share Your Location

By accepting you will be accessing a service provided by a third-party external to https://www.drcarney.com/